Ignite Creation Date:
2024-05-06 @ 2:11 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04246866
Status:
COMPLETED
Last Update Posted:
2021-02-11
First Post:
2020-01-06
Brief Title:
First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration
Sponsor:
Gemini Therapeutics Inc
Organization:
Gemini Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Retinal Degeneration |
| Dry Age-related Macular Degeneration |
| Geographic Atrophy |
| Macular Degeneration |
| Retinal Disease |
Keywords: